ClinicalTrials.Veeva

Menu

Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients

M

Makati Medical Center

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Dietary Supplement: Extra Virgin Olive Oil (EVOO)

Study type

Interventional

Funder types

Other

Identifiers

NCT04077216
MakatiMedCtr

Details and patient eligibility

About

Extra virgin olive oil (EVOO) is known for its cardiovascular effects and its effect on glucose lowering. However, the effects of EVOO on the blood glucose of Type 2 Diabetes Mellitus Filipino patients has not been studied. The investigators aimed to determine whether a significant difference exists in meals containing EVOO versus meals without EVOO among Type 2 Diabetes Mellitus patients.

Thirteen patients were included in this randomized controlled cross-over trial. They were randomized to receive a meal with or without EVOO followed by a one week wash out period, where they were given the other intervention. The primary outcome is the trans-meal blood glucose, which is calculated as the percent change in 2-hour postprandial blood glucose.

Full description

During their first visit, the participants were oriented on the conduct of the study. They were advised to be compliant with their medications throughout the duration of the trial.

On their second visit, participants were asked to do a six to eight-hour overnight fast, and their fasting blood sugar was drawn. Serum samples were analyzed through the hexokinase method. The participants were then randomly allocated (first allocation) by the dietician through a coin toss to receive a standard breakfast without EVOO or a meal admixed with one tablespoon of EVOO. The standard meals were labeled with serial numbers, and both the participants and the investigator were blinded to the intervention. The meals were consumed steadily in 15 to 20 minutes, after which, the food containers were collected to ensure its full consumption. Breakfast was chosen in order to avoid a second meal bias. The participants were asked to sit in the waiting area of the laboratory until the 2-hour postprandial blood sugar was due to be drawn.

After a one-week washout period, the participants were asked to come back for a cross over to the other treatment arm (second allocation). The participants were given the same test meal to ensure that that the glycemic index of the food remained constant.

Enrollment

14 patients

Sex

All

Ages

30 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients aged 30-65 years old
  2. diagnosed with Type 2 Diabetes Mellitus
  3. body mass index under the overweight or obese class I category (by Asia Pacific guidelines)

Exclusion criteria

  1. pregnant patients
  2. patients with history of frequent hypoglycemic episodes
  3. those at high risk of developing ketoacidosis and hyperglycemic hyperosmolar syndrome
  4. those with identified acute stress during the study (illness, fever, trauma leading to hospitalization)
  5. current intake of steroids
  6. olive oil allergy or intolerance
  7. digestive disorders

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

14 participants in 2 patient groups

Group A
Experimental group
Description:
Initially received the test meal with EVOO, then on crossover, received the meal without EVOO
Treatment:
Dietary Supplement: Extra Virgin Olive Oil (EVOO)
Group B
No Intervention group
Description:
Initially received the test meal without EVOO, then on crossover, received the meal without EVOO

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems